Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2026-02-06 @ 3:08 AM
Study NCT ID:
NCT04620135
Status:
COMPLETED
Last Update Posted:
2023-02-27
First Post:
2020-10-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Sponsor:
Aerie Pharmaceuticals
Organization: